SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Retension Pharmaceuticals Appoints Robert Wong Chief Accounting Officer

Robert Wong will become vice president and chief accounting officer effective November 2, 2026. The company also entered into an offer letter outlining his compensation.

RTSN

Related stories